Change in Watt’s Connectedness Scale, Subscales by Treatment Group. by Benjamin R. Lewis (22279166)

Subjects:

Primary and secondary efficacy end points (intention-to-treat population). by Benjamin R. Lewis (22279166)

Subjects:

Demographic and clinical characteristics of participants at baseline. by Benjamin R. Lewis (22279166)

Subjects:

Change in QIDS-SR-16 and MBI-HSS-MP by Treatment Group. by Benjamin R. Lewis (22279166)

Subjects:

Change in Demoralization Scale (DSII) by Treatment Group. by Benjamin R. Lewis (22279166)

Subjects:

Change in Watt’s Connectedness Scale (WCS), General Connectedness by Treatment Group. by Benjamin R. Lewis (22279166)

Subjects:

Development of a CRISPR/Cas-Based Detection Platform for Tracking Decreased Susceptibility to Cephalosporins in Neisseria gonorrheae by Ziyuan Zhao (2889005)

“…Developing efficient and accurate detection of resistant strains is urgently needed for their management and treatment. We have developed the Multiplex Integrated RPA-CRISPR/Cas12a detection Assay (MIRCA) for simultaneous detection of Neisseria gonorrheae (<i>Ng</i>) and mutations with decreased susceptibility to cephalosporins. …”

The effect of pre-RT D-dimer levels on post-RT changes in D-dimer levels and on survival rates. by Huriye Senay Kiziltan (22298378)

Subjects:

ROC curve according to their D-dimer values in patients with PFS ≥ 1 year and those with PFS < 1 year. p < 0.001 (95% CI: 4-21). by Huriye Senay Kiziltan (22298378)

Subjects:

Kaplan Meier curves of OS and PFS according to RT and/or CRT response. by Huriye Senay Kiziltan (22298378)

Subjects:

Univariate and multivariable analyses for progression free survival. by Huriye Senay Kiziltan (22298378)

Subjects:

Kaplan Meier curves of OS and PFS according to different pre-RT different D-dimer values. by Huriye Senay Kiziltan (22298378)

Subjects:

Univariate and multivariable analyses for OS. by Huriye Senay Kiziltan (22298378)

Subjects:

Characteristics of LC patients. by Huriye Senay Kiziltan (22298378)

Subjects:

Decision curve analysis according to t D-dimer values in patients with OS ≥ 1 year and those with OS < 1 year. by Huriye Senay Kiziltan (22298378)

Subjects:

Kaplan Meier curves of OS and PFS according to d-dimer values comparing OS rates between patients with D-dimer levels ≤ 0.3 µg/mL and those with levels > 0.3 µg/mL. by Huriye Senay Kiziltan (22298378)

Subjects:

ROC curve according to their D-dimer values in patients with OS ≥ 1 year and those with OS < 1 year. p < 0.001 (95% CI: 6-24). by Huriye Senay Kiziltan (22298378)

Subjects:

Flowchart of this study. by Huriye Senay Kiziltan (22298378)

Subjects:

RT characteristics and D-dimer, OS and PFS of patients. by Huriye Senay Kiziltan (22298378)

Subjects:

<i>rfbV</i> gene triplication in S. Paratyphi A increases VL O-ag production and reduces C3b deposition. by Fermin E. Guerra (6084545)

“…</i> Paratyphi A with a single gene copy of <i>rfbV</i> is less resistant to serum killing compared to wild-type <i>S.…”